Back to Agenda
SESSION 11: Biosimilars
Session Chair(s)
Ali AlSamil
Head of Biotech and Biosimilar Products Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
SESSION 10: Biosimilars
Speaker(s)
Ali AlSamil
Head of Biotech and Biosimilar Products Department, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Sarah Yim, MD
Director, Office of Therapeutic Biologics and Biosimilars, OND, CDER, FDA, United States
Mohammed H. Aldosari, PHD
Director of Biological Products Directorete, Saudi Food and Drug Authority (SFDA), Saudi Arabia
Anne Cook
Expert Quality Assessor (Biologicals) Healthcare, Quality and Access group, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Andrea Laslop, MD
Former Head of Scientific Office, AGES & Regulatory expert, lecturer, Malta Medicines Authority, University of Innsbruck, Austria
Virginia Acha, PHD, MSC
Global Lead, Global Regulatory Policy, Merck & Co., Inc., United States
Panellist(s) Invited
, Qatar
Have an account?